Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy
Georges M. Nemer, Nagham Nafiz Hendi · Pharmaceutical science. · 2023
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Pharmaceutical science. · OpenAlex · book-chapter · 2023
Abstract
Cardiovascular diseases (CVD) represent a substantial global health burden, leading to significant morbidity and mortality rates. However, the efficacy and safety of CVD therapies are markedly influenced by individual variability in drug responses and adverse reactions, often attributable to genetic factors. This chapter discusses how pharmacogenomics impacts the safety and efficacy of cardiovascular therapies through advanced genetic testing methods, like genome-wide association studies, polygenic risk scores, and multi-omics analyses.
Additionally, the chapter addresses challenges and future perspectives, with a focus on the role of artificial intelligence and machine learning in integrating pharmacogenomics and genotype-based personalized interventions into the routine CVD care to improve long-term health outcomes.
Open the resolved locator · 10.5772/intechopen.113236
Metadata licence: OpenAlex metadata (CC0)